NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/02/2023
Voltar para busca
Dado oficial do USPTO
HEALIOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
21/04/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
26/06/2018
Data de registro
07/02/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/02/2023
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Minato-ku, Tokyo, JP
Examinador
FOSDICK, GEOFFREY
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
H. K. (pessoa física)
Representantes
M. Scott Alprin ALPRIN LAW OFFICES PC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmiccentral nervousrespiratorycardiovascular disease; biological preparations for veterinary purposes for the treatment of cancerliver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancerliver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy productsgenetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesiaoncologyurology and gynecology
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/11/2022
PUBO
PUBLISHED FOR OPPOSITION
22/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
18/10/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
14/10/2022
OTHE
CASE RETURNED TO EXAMINATION
12/10/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/10/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
07/10/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/10/2022
APET
ASSIGNED TO PETITION STAFF
05/10/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
08/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/03/2022
EX4G
SOU EXTENSION 4 GRANTED
25/03/2022
EXT4
SOU EXTENSION 4 FILED
25/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
25/03/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/10/2021
EX3G
SOU EXTENSION 3 GRANTED
14/10/2021
EXT3
SOU EXTENSION 3 FILED
14/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
14/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/03/2021
EX2G
SOU EXTENSION 2 GRANTED
17/03/2021
EXT2
SOU EXTENSION 2 FILED
17/03/2021
EEXT
SOU TEAS EXTENSION RECEIVED
17/03/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/08/2020
EX1G
SOU EXTENSION 1 GRANTED
17/08/2020
EXT1
SOU EXTENSION 1 FILED
17/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
17/08/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/03/2020
PUBO
PUBLISHED FOR OPPOSITION
17/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/02/2020
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
08/11/2019
GECD
ACTION DENYING REQ FOR RECON E-MAILED
08/11/2019
CNCF
ACTION CONTINUING FINAL - COMPLETED
08/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2019
ALIE
ASSIGNED TO LIE
30/10/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/10/2019
EXPI
EX PARTE APPEAL-INSTITUTED
23/10/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
23/10/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
23/10/2019
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
17/07/2019
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
17/07/2019
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
17/07/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
01/07/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/04/2019
GNFR
FINAL REFUSAL E-MAILED
23/04/2019
CNFR
FINAL REFUSAL WRITTEN
23/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2019
DRRR
DIVISIONAL REQUEST RECEIVED
09/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/10/2018
GNRT
NON-FINAL ACTION E-MAILED
16/10/2018
CNRT
NON-FINAL ACTION WRITTEN
16/10/2018
DOCK
ASSIGNED TO EXAMINER
16/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2018
NWAP
NEW APPLICATION ENTERED
29/06/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEALIOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.